Related Experiment Videos
Use of stress testing to evaluate patients with recurrent chest pain after percutaneous coronary revascularization
S Rosanio1, M Tocchi, G A Stouffer
1Department of Medicine, The University of Texas Medical Branch at Galveston, 77555-1064, USA.
Insights
Noninvasive stress testing after percutaneous transluminal coronary angioplasty (PTCA) can help detect restenosis. Stress echocardiography is more specific than nuclear imaging for early detection of myocardial ischemia post-PTCA.
Area of Science:
- Cardiology
- Diagnostic Imaging
- Interventional Cardiology
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for coronary artery disease.
- Chest pain recurrence after PTCA necessitates accurate diagnostic tools to assess restenosis.
- High rates of restenosis (up to 50%) underscore the need for reliable noninvasive testing.
Observation:
- Stress testing sensitivity and specificity vary based on timing post-PTCA.
- Nuclear imaging may show perfusion defects in asymptomatic patients early after PTCA, lacking specificity.
- Stress echocardiography detects wall motion abnormalities, offering better early specificity for ischemia and restenosis.
Findings:
- Nuclear imaging within 4-6 weeks post-PTCA has limited specificity for restenosis due to spontaneous scan normalization.
- Stress echocardiography shows promise for early, specific detection of myocardial ischemia and restenosis.
- Both echocardiography and nuclear imaging are effective for identifying restenosis in patients with chest pain >6 weeks post-PTCA.
Implications:
- Choosing the right stress test and timing is crucial for accurate restenosis diagnosis post-PTCA.
- Stress echocardiography may be preferred for early noninvasive assessment of ischemia after PTCA.
- Improved diagnostic strategies can reduce unnecessary coronary angiography and guide patient management.
Abstract:
Controversy exists regarding the diagnostic accuracy, optimal technique, and timing of noninvasive stress testing after percutaneous transluminal coronary angioplasty (PTCA). Many patients return with chest pain after PTCA, and because the incidence of restenosis has been reported to be as high as 50%, a noninvasive test with a high predictive value is needed to reduce the need for unnecessary coronary angiography. Studies have shown that the sensitivity and specificity of stress testing varies depending on the amount of time elapsed since the procedure. Soon after a successful PTCA, perfusion defects on nuclear imaging following exercise or pharmacologic stress may be detected in asymptomatic patients without angiographic restenosis. In many patients, abnormal stress myocardial perfusion scans will normalize spontaneously, and thus stress testing with nuclear imaging within 4 to 6 weeks of PTCA lacks specificity for detecting restenosis. In contrast, stress echocardiography which detects wall motion abnormalities rather than perfusion mismatch has been reported to offer more specific information on myocardial ischemia and restenosis early after PTCA. In patients who develop chest pain more than 6 weeks after PTCA, the ability to accurately identify restenosis is shared by both echocardiographic and nuclear imaging methods. The purpose of this review is to clarify the strengths, pitfalls, and prognostic value of different stress modalities and cardiac imaging techniques in patients who develop chest pain within 6 months of undergoing PTCA.